Clinical trial
Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in…
NCT00076375 · Nucryst Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00076375 |
|---|---|
| Title | Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Two Concentrations of Nanocrystalline Silver Cream (NPI) Applied Twice Daily in Adults With Mild to Moderate Atopic Dermatitis |
| Lead sponsor | Nucryst Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis, Eczema |
| Intervention type | Drug |
| Interventions | Nanocrystalline silver cream (NPI) |
| Enrollment | 180 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2004 |
| First posted | Jan 23, 2004 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: